| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2091314 | SIRT6 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 19 | - |
PV=1 FDR=1 FC=0.169 |
|
| 2091315 | SIRT6 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 19 | - |
PV=1 FDR=1 FC=0.056 |
|
| 2091316 | TINF2 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 14 | - |
PV=1 FDR=1 FC=0.028 |
|
| 2091317 | TATDN3 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 1 | - |
PV=0.001 FDR=0.076 FC=0.104 |
